SlideShare una empresa de Scribd logo
1 de 19
Descargar para leer sin conexión
Equal Partnership: case studies
         from BIOTEC




          Bubpha Techapattaraporn
        BioLaw Research Unit, Bioresources
         Technology Unit, BIOTEC, Thailand
OUTLINES

1.   Thai Biodiversity;
2.   Thailand and ABS regulation;
3.   BIOTEC: the introduction;
4.   ABS case studies at BIOTEC
5.   Conclusion
Biodiversity for bioresources
 Thailand accounts for ca. 7-10 % of the world’s species richness




                                       Seed and Leaf-litter Fungi        Marine and Mangrove Fungi




                                                                    Freshwater Fungi




                                                                    Basidiomycota
Overview of Thai ABS rules and regulations


                                                2012
                             2011 Enactment of            Signing the
                                                          NP
                                     - The National       -Under
              2004                   Committee on         consideration
                                     Conservation         and
                     Ratifying the
                                     Sustainable Use of   preparation of
                     CBD
1999                                 Biodiversity’s       ratifying;
   Enactment of                      Regulation on        -More of ABS
   - Thai PVPA Act                   Criteria and         Rules and
                                     Methods for ABS      Regulation??
   -The Protection and               from the Use of BR
   Enhancement of Thai               (Thai ABS
   Traditional Medicinal             Regulation)
   Wisdom Act
BIOTEC at a glance
Status:       Established in 1983
              A member of the National Science and Technology Development Agency .
              NSTDA is a quasi-government agency, affiliated to Ministry of Science and
              Technology

Location:     Headquarter at Thailand Science Park, 30 kilometers north of Bangkok


Personnel:    570 (470 research and scientific staff and approx. 170 Ph.Ds)

Budget:       Approx 20 million USD (from government and revenue from service
              provision and commercialization)

5 Research Units at Thailand Science Park & 10 Satellite Labs at various universities and
government agencies
NSTDA Organization

                                      NSTDA Board
                       chaired by Minister of Science and Technology


                                                                        established by Sci. &
                                                                        Tech. Dev. Act. in 1991




                       1983                                 1985                     1985



                                          2006                               2003

NSTDA     : National Science and Technology Development Agency
BIOTEC    : National Center for Genetic Engineering and Biotechnology
MTEC      : National Metal and Materials Technology Center
NECTEC    : National Electronics and Computer Technology Center
NANOTEC   : National Nanotechnology Center                                                  1
TMC       : Technology Management Center
B TE R & C F
 IO C oles ore unctions

Core Functions
RDE
(Conduct research on basic science, platform technology, applied science)
TT
(Technology transfer to industry and public sector)
Infrastructure
Develop and maintain (support the establishment and maintenance of specialized
units at universities, conduct policy research, support and subsidize service labs
and maintain public databases)
HRD
(Provide scholarships, organize training, support the establishment of new graduate
program in universities)


Support Functions
- Create public relations and provide science awareness
- Seek and maintain international relations
Cordyceps sp.
BIOTEC
Hirsutella nivea on hopper
BCC 2594, collected from Homoptera
leaf-hopper, Khao Yai National Park,
Hirsutella nivea BCC 2594
(MeOH extract of mycelia)                                            Hirsutellones A-E
                            H   O                                        OH                                      OH
                                                                                                        H
                    O                                        O           NH
            O                   NH                  O                                      O        O       O NH
       H        H                               H        H                           H          H
                        H                                        H
                            O                                        O                                       O


           HH               R                       HH               R                     HH
H3 C                                   H3 C                                   H3C

       1 : R = H (A)                           2 : R = H (B)                                   3 (C)
       4 : R = CH3 (D)                         5 : R = CH3 (E)



           Compound                   Anti-TB                    Cytotoxicity
                                     MIC; µg/mL                          vero; IC50 µg/mL

            1                          0.78                                         >50
            2                          0.78                                         >50
            3                          0.78                                         12
            4                          3.13                                   not tested


                                              Isaka, M., et al., Tetrahedron Lett. (2005), 61, 5577-5583
Research at Bioresources Technology Unit, BIOTEC
                               Culture-dependent
 Conservation                  approach
 and microbial
 identification
                                                                  Academics


 Utilization of
   Microbes                                                         Industry

    Biocontrol
Bioactive compounds
     Enzymes                                                     Conservation
High-value products


                               Culture-independent
                               approach
 Management
 of microbes
                      Bioresources    Screening      Value-added products
BIOTEC-NOVARTIS

Objective: to find potential use of
microorganisms and natural compounds as
sources of potential new medicines.

3 Phases of collaboration:
 1st: 2005-2008
 2nd: 2008-2011
 3rd : 2011-2014
The contributions
         BIOTEC                     NOVARTIS

• Diversity of microbes in   • Technology transfer
  Thailand;                    via training
• Expertise in knowledge       (internship, experts,
  of microorganisms, i.e.      and seminar);
  collection,                • Consultant
  identification,
  preservation, isolation
  and elucidation of pure
  natural compound;
The achievement
          BIOTEC                      NOVARTIS

• Capacity building via       • Diversity of compounds
  technology transfer (able     (7,200 microbial isolates
  to automate and improve       and 115 pure
  its extraction and            compounds have been
  chemical screening            evaluated against a
  system, actenomycetes         battery of drug targets).
  expert);
• Enable BIOTEC to
  accumulate more strains;
• Able to set different
  research directions.
ABS mechanisms

 Equal partnership (based on

complementary expertise of both parties)

 Agreement: negotiation (based on the
concept of Mutually Agreed Terms)
Conclusion: Factors for the success of equal
                    partnership


•   Organisation’s vision and policy;
•   Expertise of organisation;
•   Trust between involved parties;
•   Simple ABS rules and regulation (Mutually
    agreed terms)
Acknowledgement

1.   Dr. Kanyawim Kirtikara
2.   Dr. Lily Eurwilaichitr
3.   Ms. Sronkanok Tangjaijit
4.   Ms. Suwanee Chunhametha
5.   Dr. Vanicha Vichai
Thank you very much

Más contenido relacionado

Destacado

Traditional Sericulture Community in Nong Sung District of Mukdahan Province,...
Traditional Sericulture Community in Nong Sung District of Mukdahan Province,...Traditional Sericulture Community in Nong Sung District of Mukdahan Province,...
Traditional Sericulture Community in Nong Sung District of Mukdahan Province,...ExternalEvents
 
How much protected area is enough to protect biodiversity in Thailand
How much protected area is enough to protect biodiversity in ThailandHow much protected area is enough to protect biodiversity in Thailand
How much protected area is enough to protect biodiversity in Thailandtrisurat2000
 
Green the World Lesson 1
Green the World Lesson 1Green the World Lesson 1
Green the World Lesson 1TeacherAndrew
 
Business Opportunities in Thailand
Business Opportunities in ThailandBusiness Opportunities in Thailand
Business Opportunities in ThailandChanin Khaochan
 
Biodiversity Loss in Thailand
Biodiversity Loss in ThailandBiodiversity Loss in Thailand
Biodiversity Loss in Thailandtrisurat2000
 
Benefits of biodiversity-CBM
Benefits of biodiversity-CBMBenefits of biodiversity-CBM
Benefits of biodiversity-CBMTFTProject2013
 

Destacado (7)

Traditional Sericulture Community in Nong Sung District of Mukdahan Province,...
Traditional Sericulture Community in Nong Sung District of Mukdahan Province,...Traditional Sericulture Community in Nong Sung District of Mukdahan Province,...
Traditional Sericulture Community in Nong Sung District of Mukdahan Province,...
 
How much protected area is enough to protect biodiversity in Thailand
How much protected area is enough to protect biodiversity in ThailandHow much protected area is enough to protect biodiversity in Thailand
How much protected area is enough to protect biodiversity in Thailand
 
Thailand: An Asian Hub, A World of Opportunities (BIO 2015)
Thailand: An Asian Hub, A World of Opportunities (BIO 2015)Thailand: An Asian Hub, A World of Opportunities (BIO 2015)
Thailand: An Asian Hub, A World of Opportunities (BIO 2015)
 
Green the World Lesson 1
Green the World Lesson 1Green the World Lesson 1
Green the World Lesson 1
 
Business Opportunities in Thailand
Business Opportunities in ThailandBusiness Opportunities in Thailand
Business Opportunities in Thailand
 
Biodiversity Loss in Thailand
Biodiversity Loss in ThailandBiodiversity Loss in Thailand
Biodiversity Loss in Thailand
 
Benefits of biodiversity-CBM
Benefits of biodiversity-CBMBenefits of biodiversity-CBM
Benefits of biodiversity-CBM
 

Similar a Bubpha techapattaraporn equal partnership case studies from biotec

Network of International Exchange of Microbes under the ACM (NIEMA)
Network of International Exchange of Microbes under the ACM (NIEMA)Network of International Exchange of Microbes under the ACM (NIEMA)
Network of International Exchange of Microbes under the ACM (NIEMA)tbrc
 
Thailand Bioresource Research Center (TBRC)
Thailand Bioresource Research Center (TBRC)Thailand Bioresource Research Center (TBRC)
Thailand Bioresource Research Center (TBRC)tbrc
 
Standards in bioresource centers: practice in Japan
Standards in bioresource centers: practice in JapanStandards in bioresource centers: practice in Japan
Standards in bioresource centers: practice in Japantbrc
 
International Journal of Biometrics and Bioinformatics(IJBB) Volume (4) Issu...
International Journal of Biometrics and Bioinformatics(IJBB)  Volume (4) Issu...International Journal of Biometrics and Bioinformatics(IJBB)  Volume (4) Issu...
International Journal of Biometrics and Bioinformatics(IJBB) Volume (4) Issu...CSCJournals
 
Technology Insight Report - Probiotics
Technology Insight Report - ProbioticsTechnology Insight Report - Probiotics
Technology Insight Report - ProbioticsPrashant Nair
 
The Regulatory Status of Genome Editing Technology in Thailand
The Regulatory Status of Genome Editing Technology in Thailand The Regulatory Status of Genome Editing Technology in Thailand
The Regulatory Status of Genome Editing Technology in Thailand apaari
 
Eb ti sept 29 meeting biosafety-agri biotech-final
Eb ti sept 29 meeting biosafety-agri biotech-finalEb ti sept 29 meeting biosafety-agri biotech-final
Eb ti sept 29 meeting biosafety-agri biotech-finalGTK1974
 
BIOLOGY FOR ENGINEERS REQUIRED TO ENHANCE KNOWLEDGE
BIOLOGY FOR ENGINEERS REQUIRED TO ENHANCE KNOWLEDGEBIOLOGY FOR ENGINEERS REQUIRED TO ENHANCE KNOWLEDGE
BIOLOGY FOR ENGINEERS REQUIRED TO ENHANCE KNOWLEDGEkeshavmech2008
 
Biotechnology grade 10
Biotechnology grade 10Biotechnology grade 10
Biotechnology grade 10SaminaTariq5
 
BIOINFO unit 1.pptx
BIOINFO unit 1.pptxBIOINFO unit 1.pptx
BIOINFO unit 1.pptxrnath286
 
Biotechnology as a career
Biotechnology as a careerBiotechnology as a career
Biotechnology as a careerIshita Sidhu
 
Pharmaceutical Biotechnology on Modern Technological Platform
Pharmaceutical Biotechnology on Modern Technological PlatformPharmaceutical Biotechnology on Modern Technological Platform
Pharmaceutical Biotechnology on Modern Technological PlatformAshikur Rahman
 
TCI Quarterly Newsletter - July 2023
TCI Quarterly Newsletter - July 2023TCI Quarterly Newsletter - July 2023
TCI Quarterly Newsletter - July 2023AshutoshKumar13713
 
National institue of biotechnology
National institue of biotechnologyNational institue of biotechnology
National institue of biotechnologyAbirHasanJoy1
 

Similar a Bubpha techapattaraporn equal partnership case studies from biotec (20)

Network of International Exchange of Microbes under the ACM (NIEMA)
Network of International Exchange of Microbes under the ACM (NIEMA)Network of International Exchange of Microbes under the ACM (NIEMA)
Network of International Exchange of Microbes under the ACM (NIEMA)
 
Patenting biotechnology inventions
Patenting biotechnology inventionsPatenting biotechnology inventions
Patenting biotechnology inventions
 
Thailand Bioresource Research Center (TBRC)
Thailand Bioresource Research Center (TBRC)Thailand Bioresource Research Center (TBRC)
Thailand Bioresource Research Center (TBRC)
 
Standards in bioresource centers: practice in Japan
Standards in bioresource centers: practice in JapanStandards in bioresource centers: practice in Japan
Standards in bioresource centers: practice in Japan
 
Kassahun Tesfaye
Kassahun Tesfaye  Kassahun Tesfaye
Kassahun Tesfaye
 
International Journal of Biometrics and Bioinformatics(IJBB) Volume (4) Issu...
International Journal of Biometrics and Bioinformatics(IJBB)  Volume (4) Issu...International Journal of Biometrics and Bioinformatics(IJBB)  Volume (4) Issu...
International Journal of Biometrics and Bioinformatics(IJBB) Volume (4) Issu...
 
Technology Insight Report - Probiotics
Technology Insight Report - ProbioticsTechnology Insight Report - Probiotics
Technology Insight Report - Probiotics
 
The Regulatory Status of Genome Editing Technology in Thailand
The Regulatory Status of Genome Editing Technology in Thailand The Regulatory Status of Genome Editing Technology in Thailand
The Regulatory Status of Genome Editing Technology in Thailand
 
BIOTECHNOLOGY
BIOTECHNOLOGYBIOTECHNOLOGY
BIOTECHNOLOGY
 
Eb ti sept 29 meeting biosafety-agri biotech-final
Eb ti sept 29 meeting biosafety-agri biotech-finalEb ti sept 29 meeting biosafety-agri biotech-final
Eb ti sept 29 meeting biosafety-agri biotech-final
 
Semantic artefact and ontology services for long-term data interpretation
Semantic artefact and ontology services for long-term data interpretationSemantic artefact and ontology services for long-term data interpretation
Semantic artefact and ontology services for long-term data interpretation
 
BIOLOGY FOR ENGINEERS REQUIRED TO ENHANCE KNOWLEDGE
BIOLOGY FOR ENGINEERS REQUIRED TO ENHANCE KNOWLEDGEBIOLOGY FOR ENGINEERS REQUIRED TO ENHANCE KNOWLEDGE
BIOLOGY FOR ENGINEERS REQUIRED TO ENHANCE KNOWLEDGE
 
bioinformatics enabling knowledge generation from agricultural omics data
bioinformatics enabling knowledge generation from agricultural omics databioinformatics enabling knowledge generation from agricultural omics data
bioinformatics enabling knowledge generation from agricultural omics data
 
Biotechnology grade 10
Biotechnology grade 10Biotechnology grade 10
Biotechnology grade 10
 
BIOINFO unit 1.pptx
BIOINFO unit 1.pptxBIOINFO unit 1.pptx
BIOINFO unit 1.pptx
 
Biotechnology as a career
Biotechnology as a careerBiotechnology as a career
Biotechnology as a career
 
Pharmaceutical Biotechnology on Modern Technological Platform
Pharmaceutical Biotechnology on Modern Technological PlatformPharmaceutical Biotechnology on Modern Technological Platform
Pharmaceutical Biotechnology on Modern Technological Platform
 
TCI Quarterly Newsletter - July 2023
TCI Quarterly Newsletter - July 2023TCI Quarterly Newsletter - July 2023
TCI Quarterly Newsletter - July 2023
 
National institue of biotechnology
National institue of biotechnologyNational institue of biotechnology
National institue of biotechnology
 
Indo uk seminar
Indo uk seminarIndo uk seminar
Indo uk seminar
 

Más de International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

Más de International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) (20)

Peter Hotez, Baylor College of Medicine
Peter Hotez,  Baylor College of MedicinePeter Hotez,  Baylor College of Medicine
Peter Hotez, Baylor College of Medicine
 
Session1: Patrick Deboyser, European Union
Session1: Patrick Deboyser, European UnionSession1: Patrick Deboyser, European Union
Session1: Patrick Deboyser, European Union
 
Session 4: Bejon Misra Partnership for Safe Medicines (PSM) INDIA /
Session 4: Bejon Misra Partnership for Safe Medicines (PSM) INDIA / Session 4: Bejon Misra Partnership for Safe Medicines (PSM) INDIA /
Session 4: Bejon Misra Partnership for Safe Medicines (PSM) INDIA /
 
Session 4 Sabine Walser Council of Europe / Legal framework necessary for eff...
Session 4 Sabine Walser Council of Europe / Legal framework necessary for eff...Session 4 Sabine Walser Council of Europe / Legal framework necessary for eff...
Session 4 Sabine Walser Council of Europe / Legal framework necessary for eff...
 
Session 4: Domenico Di Giorgio AIFA Italy / SPOC model cooperation against co...
Session 4: Domenico Di Giorgio AIFA Italy / SPOC model cooperation against co...Session 4: Domenico Di Giorgio AIFA Italy / SPOC model cooperation against co...
Session 4: Domenico Di Giorgio AIFA Italy / SPOC model cooperation against co...
 
Session 3: Salmah Bahri - Ministry of Health, Malaysia / Monitoring of Counte...
Session 3: Salmah Bahri - Ministry of Health, Malaysia / Monitoring of Counte...Session 3: Salmah Bahri - Ministry of Health, Malaysia / Monitoring of Counte...
Session 3: Salmah Bahri - Ministry of Health, Malaysia / Monitoring of Counte...
 
Session 4: Sheuan Lee, International Council of Nurses (ICN) / Practices and ...
Session 4: Sheuan Lee, International Council of Nurses (ICN) / Practices and ...Session 4: Sheuan Lee, International Council of Nurses (ICN) / Practices and ...
Session 4: Sheuan Lee, International Council of Nurses (ICN) / Practices and ...
 
Session 3: Ivan Ho Pfizer / Counterfeit Medicines Threat to Patient Health an...
Session 3: Ivan Ho Pfizer / Counterfeit Medicines Threat to Patient Health an...Session 3: Ivan Ho Pfizer / Counterfeit Medicines Threat to Patient Health an...
Session 3: Ivan Ho Pfizer / Counterfeit Medicines Threat to Patient Health an...
 
Session 3: Fu-Wen Chang, nternational Federation of Pharmaceutical Wholesaler...
Session 3: Fu-Wen Chang, nternational Federation of Pharmaceutical Wholesaler...Session 3: Fu-Wen Chang, nternational Federation of Pharmaceutical Wholesaler...
Session 3: Fu-Wen Chang, nternational Federation of Pharmaceutical Wholesaler...
 
Afternoon Session Opening: Jim Dahl, Partnership for Safe Medicines
Afternoon Session Opening: Jim Dahl, Partnership for Safe MedicinesAfternoon Session Opening: Jim Dahl, Partnership for Safe Medicines
Afternoon Session Opening: Jim Dahl, Partnership for Safe Medicines
 
Session 2: Mike Rose, Johnson & Johnson / Serialization and Traceability GS1 ...
Session 2: Mike Rose, Johnson & Johnson / Serialization and Traceability GS1 ...Session 2: Mike Rose, Johnson & Johnson / Serialization and Traceability GS1 ...
Session 2: Mike Rose, Johnson & Johnson / Serialization and Traceability GS1 ...
 
Session 2: Scott Kammer, Rx360
Session 2: Scott Kammer, Rx360 Session 2: Scott Kammer, Rx360
Session 2: Scott Kammer, Rx360
 
Opening Session - Cyntia Genole, IFPMA
Opening Session - Cyntia Genole, IFPMAOpening Session - Cyntia Genole, IFPMA
Opening Session - Cyntia Genole, IFPMA
 
Session 1 - Mark Paxton, US FDA / APEC Roadmap to Promote Global Medical Prod...
Session 1 - Mark Paxton, US FDA / APEC Roadmap to Promote Global Medical Prod...Session 1 - Mark Paxton, US FDA / APEC Roadmap to Promote Global Medical Prod...
Session 1 - Mark Paxton, US FDA / APEC Roadmap to Promote Global Medical Prod...
 
Bringing Psoriasis into the Light, Kim kjoeller, Leo Pharma
Bringing Psoriasis into the Light, Kim kjoeller, Leo PharmaBringing Psoriasis into the Light, Kim kjoeller, Leo Pharma
Bringing Psoriasis into the Light, Kim kjoeller, Leo Pharma
 
IFPA Psoriasis Presentation
IFPA Psoriasis PresentationIFPA Psoriasis Presentation
IFPA Psoriasis Presentation
 
International Psoriasis Council, Steve O'Dell
International Psoriasis Council, Steve O'DellInternational Psoriasis Council, Steve O'Dell
International Psoriasis Council, Steve O'Dell
 
Manaement of Psoriasis in Low Income Countries
Manaement of Psoriasis in Low Income CountriesManaement of Psoriasis in Low Income Countries
Manaement of Psoriasis in Low Income Countries
 
IFPMA: From Manufacturing to the Vaccinee – the Complex Journey of a Vaccine
IFPMA: From Manufacturing to the Vaccinee – the Complex Journey of a VaccineIFPMA: From Manufacturing to the Vaccinee – the Complex Journey of a Vaccine
IFPMA: From Manufacturing to the Vaccinee – the Complex Journey of a Vaccine
 
The Complex Journey of a Vaccine
The Complex Journey of a VaccineThe Complex Journey of a Vaccine
The Complex Journey of a Vaccine
 

Bubpha techapattaraporn equal partnership case studies from biotec

  • 1. Equal Partnership: case studies from BIOTEC Bubpha Techapattaraporn BioLaw Research Unit, Bioresources Technology Unit, BIOTEC, Thailand
  • 2. OUTLINES 1. Thai Biodiversity; 2. Thailand and ABS regulation; 3. BIOTEC: the introduction; 4. ABS case studies at BIOTEC 5. Conclusion
  • 3. Biodiversity for bioresources Thailand accounts for ca. 7-10 % of the world’s species richness Seed and Leaf-litter Fungi Marine and Mangrove Fungi Freshwater Fungi Basidiomycota
  • 4. Overview of Thai ABS rules and regulations 2012 2011 Enactment of Signing the NP - The National -Under 2004 Committee on consideration Conservation and Ratifying the Sustainable Use of preparation of CBD 1999 Biodiversity’s ratifying; Enactment of Regulation on -More of ABS - Thai PVPA Act Criteria and Rules and Methods for ABS Regulation?? -The Protection and from the Use of BR Enhancement of Thai (Thai ABS Traditional Medicinal Regulation) Wisdom Act
  • 5. BIOTEC at a glance Status: Established in 1983 A member of the National Science and Technology Development Agency . NSTDA is a quasi-government agency, affiliated to Ministry of Science and Technology Location: Headquarter at Thailand Science Park, 30 kilometers north of Bangkok Personnel: 570 (470 research and scientific staff and approx. 170 Ph.Ds) Budget: Approx 20 million USD (from government and revenue from service provision and commercialization) 5 Research Units at Thailand Science Park & 10 Satellite Labs at various universities and government agencies
  • 6. NSTDA Organization NSTDA Board chaired by Minister of Science and Technology established by Sci. & Tech. Dev. Act. in 1991 1983 1985 1985 2006 2003 NSTDA : National Science and Technology Development Agency BIOTEC : National Center for Genetic Engineering and Biotechnology MTEC : National Metal and Materials Technology Center NECTEC : National Electronics and Computer Technology Center NANOTEC : National Nanotechnology Center 1 TMC : Technology Management Center
  • 7. B TE R & C F IO C oles ore unctions Core Functions RDE (Conduct research on basic science, platform technology, applied science) TT (Technology transfer to industry and public sector) Infrastructure Develop and maintain (support the establishment and maintenance of specialized units at universities, conduct policy research, support and subsidize service labs and maintain public databases) HRD (Provide scholarships, organize training, support the establishment of new graduate program in universities) Support Functions - Create public relations and provide science awareness - Seek and maintain international relations
  • 10. Hirsutella nivea on hopper BCC 2594, collected from Homoptera leaf-hopper, Khao Yai National Park,
  • 11. Hirsutella nivea BCC 2594 (MeOH extract of mycelia) Hirsutellones A-E H O OH OH H O O NH O NH O O O O NH H H H H H H H H O O O HH R HH R HH H3 C H3 C H3C 1 : R = H (A) 2 : R = H (B) 3 (C) 4 : R = CH3 (D) 5 : R = CH3 (E) Compound Anti-TB Cytotoxicity MIC; µg/mL vero; IC50 µg/mL 1 0.78 >50 2 0.78 >50 3 0.78 12 4 3.13 not tested Isaka, M., et al., Tetrahedron Lett. (2005), 61, 5577-5583
  • 12. Research at Bioresources Technology Unit, BIOTEC Culture-dependent Conservation approach and microbial identification Academics Utilization of Microbes Industry Biocontrol Bioactive compounds Enzymes Conservation High-value products Culture-independent approach Management of microbes Bioresources Screening Value-added products
  • 13. BIOTEC-NOVARTIS Objective: to find potential use of microorganisms and natural compounds as sources of potential new medicines. 3 Phases of collaboration:  1st: 2005-2008  2nd: 2008-2011  3rd : 2011-2014
  • 14. The contributions BIOTEC NOVARTIS • Diversity of microbes in • Technology transfer Thailand; via training • Expertise in knowledge (internship, experts, of microorganisms, i.e. and seminar); collection, • Consultant identification, preservation, isolation and elucidation of pure natural compound;
  • 15. The achievement BIOTEC NOVARTIS • Capacity building via • Diversity of compounds technology transfer (able (7,200 microbial isolates to automate and improve and 115 pure its extraction and compounds have been chemical screening evaluated against a system, actenomycetes battery of drug targets). expert); • Enable BIOTEC to accumulate more strains; • Able to set different research directions.
  • 16. ABS mechanisms  Equal partnership (based on complementary expertise of both parties)  Agreement: negotiation (based on the concept of Mutually Agreed Terms)
  • 17. Conclusion: Factors for the success of equal partnership • Organisation’s vision and policy; • Expertise of organisation; • Trust between involved parties; • Simple ABS rules and regulation (Mutually agreed terms)
  • 18. Acknowledgement 1. Dr. Kanyawim Kirtikara 2. Dr. Lily Eurwilaichitr 3. Ms. Sronkanok Tangjaijit 4. Ms. Suwanee Chunhametha 5. Dr. Vanicha Vichai